FOX 66 News at Ten
Story by Marilynn Marchione / ASSOCIATED PRESS
suggests that a shot every one to three months may someday give an
alternative to the daily pills that some people take now to cut their
risk of getting HIV.
The experimental drug has only been tested
for prevention in monkeys, but it completely protected them from
infection in two studies reported at an AIDS conference on Tuesday.
is the most exciting innovation in the field of HIV prevention that
I've heard recently," said Dr. Robert Grant, an AIDS expert at the
Gladstone Institutes, a foundation affiliated with the University of
California, San Francisco.
"Both groups are showing 100 percent
protection" with the drug, Grant said of the two groups of researchers.
"If it works and proves to be safe, it would allow for HIV to be
prevented with periodic injections, perhaps every three months."
a vaccine is developed, condoms are the best way to prevent infection
with the AIDS virus and many other sexually spread diseases. But not
everyone uses them, or does so all the time, so public health officials
have pursued other prevention options.
A drug used to treat
people with HIV — Gilead Science's Truvada — also is used to help
prevent infection in people who don't have the virus. A big study in gay
men a few years ago found it could cut this risk by up to 90 percent,
depending on how faithfully people take the daily pills.
research tested something that could make this type of prevention much
more practical — a long-acting experimental drug made by GlaxoSmithKline
PLC. The studies tested it in macaques exposed to a human-monkey
version of HIV.
Researchers at the Centers for Disease Control
and Prevention gave six monkeys shots of the drug every four weeks; six
others got dummy shots. All were exposed to the virus twice a week for
The monkeys who got the fake treatment were readily
infected "but the animals that received the long-acting drug remained
protected," said study leader Gerardo Garcia-Lerma of the CDC.
results mirror what was seen in the CDC's early research in monkeys on
Truvada, the pill that's available for HIV prevention now.
second study, Chasity Andrews and others at the Aaron Diamond AIDS
Research Center at Rockefeller University in New York gave eight monkeys
two shots of the drug, four weeks apart, and dummy shots to eight
others. The animals were exposed to the virus weekly for eight weeks.
Again, all animals given the fake treatment were quickly infected and
those on the drug were all protected.
To see how long a single
shot would last, they did a second study. The single shot protected 12
monkeys for about 10 weeks on average.
The dose used in a single shot corresponded to what people would get from a shot every three months, researchers said.
is really promising," said Dr. Judith Currier, an infectious disease
specialist at the University of California, Los Angeles. The research
"supports moving this forward" into human testing, she said.
is on the program committee for the meeting in Boston where the studies
were presented — the Conference on Retroviruses and Opportunistic
Infections. The New York study also was published online by the journal
Grant said the long-acting drug is chemically similar to
certain AIDS medicines sold now that are "extremely safe, well
tolerated and extremely potent." A mid-stage trial testing the
long-acting shots in people as a treatment, not a prevention, is already
underway, he said.
Wednesday, March 5 2014, 09:18 AM EST
National News Headlines
|Police charge 14-year-old girl with manslaughter in killing of western New York toddler|
|A 14-year-old girl has been arrested in the death of a 1-year-old western New York boy who was strangled.|
|6 Healthy, Energy-Filled Recipes You Can Prepare in 15 Minutes or Less|
|Become more fit and productive by sacrificing a little time every morning to whip up these snacks and meals.|
|Police: Connecticut man loses 2 fingers when ceremonial musket misfires, explodes in his hands|
|Police say a Connecticut man lost two fingers when the barrel of his ceremonial musket exploded in his hands.|
|Trial set in federal court in Virginia in unusual case of alleged Russian Taliban fighter|
|Hundreds of terror suspects have been tried in federal courts since the 2001 attacks, but a case unfolding in Virginia differs from most in at least one key respect.|
|UNH president 'troubled' over bias-free language guide|
|University of New Hampshire President Mark Huddleston attempted to distance himself and the school from a “bias-free language” guide that claims the term “American” is problematic.|
|Sept. 2 hearing set as member of Angola Three seeks freedom, end to trials in guard's death|
|A federal appeals court in New Orleans has set arguments for Sept. 2 in the case of longtime Louisiana inmate Albert Woodfox.|
|911 caller: New Mexico dispatcher had no reason to hang up while she tried to aid friend|
|A 911 caller said she was panicked about a friend being shot but stayed as calm as possible before a New Mexico dispatcher told her to "deal with it yourself" and hung up as she sought aid.|
|Rick Perry no longer emphasizing his Christian faith, in switch from last White House campaign|
|Rick Perry bragged to an Iowa barbeque crowd about the strong economy back in Texas, drew laughs comparing President Barack Obama to Jimmy Carter and won applause vowing to secure the U.S.-Mexico border.|
|California to release June water-savings report for first month of mandatory drought cutbacks|
|California regulators were expected Thursday to announce how much water cities conserved in June — the first month of mandatory cutbacks during the drought.|
|California teen charged as adult in killing of 8-year-old neighbor|
|Prosecutors charged a 15-year-old boy with murder, kidnapping and rape Wednesday in the death of an 8-year-old girl in an artists complex in a California beach town.|